Mebeverine Hydrochloride Rudipharm (Mebeverine Hydrochloride)

Mebeverine acts as a direct relaxant of gastrointestinal smooth muscle. By inhibiting calcium influx into muscle cells, it lowers intracellular calcium levels, which reduces muscle contractility and spasm without significant anticholinergic activity, thereby easing discomfort.

The appropriate dose of Mebeverine Hydrochloride is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and individual response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Mebeverine Hydrochloride in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and decide on a case‑by‑case basis. Women who are pregnant or breastfeeding should discuss use with their prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mebeverine differs from anticholinergic agents such as hyoscine butylbromide by acting directly on smooth‑muscle calcium channels rather than blocking acetylcholine receptors. This results in fewer typical anticholinergic side effects like dry mouth or blurred vision, while still providing effective spasm relief.

Mebeverine Hydrochloride should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity.

Mebeverine Hydrochloride is taken orally, usually with a glass of water. The exact timing—whether with meals or on an empty stomach—should follow the prescriber’s guidance, as absorption can be influenced by food in some cases.

Serious adverse reactions, although rare, include allergic responses such as rash, itching, swelling, angioedema, and severe skin conditions like Stevens‑Johnson syndrome. Rare cardiac arrhythmias have also been reported. Patients should seek immediate medical attention if any of these symptoms develop.

Mebeverine Hydrochloride is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is advised for patients with severe hepatic or renal impairment, and it should be avoided in those taking other potent antispasmodics without medical supervision.